Andreas Weinhaeusel
Principal Investigator:
Andreas Weinhaeusel
AIT Austrian Institute of Technology GmbH Webpage
Serum-Autoantibody testing for early diagnosis of Breast Cancer
Weitere ProjektpartnerInnen:
Christian Singer (Medizinische Universität Wien)
Florian Rüker (University of Natural Resources and Life Sciences, Vienna)
Abgeschlossen (01.10.2011 – 31.03.2015) 42 Monate
€ 579.300


Tumour auto-antibodies in the serum of patients are early indicators for breast-cancer and can be detected by protein-chips using a few micro liters of patients' serum.
Protein chip technology (AIT) and phage-display (BOKU) will be used for identification of auto-antibody-based markers. Therefore serum of patients with malignant and benign breast tumours and healthy controls will be used (MUW), then a prototype test will be developed and validated using 1200 serum samples. Hence an assay will be developed which in addition to mammography improves the detection and diagnosis of early-stage breast cancer. This project has a high long-term impact because early detection of breast cancers significantly enhances therapeutic success and women's chances of survival.


Diese Seite verwendet Cookies. Durch das Nutzen dieser Seite sind Sie mit der Verwendung von Cookies einverstanden. Details finden Sie hier.